Shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report) have been given a consensus rating of "Hold" by the six analysts that are covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and one has given a strong buy recommendation to the company.
Several brokerages recently commented on MURGY. The Goldman Sachs Group downgraded Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 24th. Hsbc Global Res upgraded Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to a "hold" rating in a research report on Monday. Finally, Barclays upgraded Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to a "strong-buy" rating in a report on Tuesday, January 28th.
View Our Latest Stock Report on Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Stock Down 0.9 %
MURGY traded down $0.12 during trading hours on Tuesday, reaching $13.71. 215,473 shares of the stock traded hands, compared to its average volume of 298,689. The company has a market cap of $91.69 billion, a price-to-earnings ratio of 8.91, a PEG ratio of 1.72 and a beta of 0.79. The firm's fifty day simple moving average is $12.65 and its two-hundred day simple moving average is $11.23. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.12 and a quick ratio of 1.12. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a fifty-two week low of $8.67 and a fifty-two week high of $14.10.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.01). The company had revenue of $16.34 billion for the quarter, compared to analyst estimates of $19.10 billion. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München had a return on equity of 18.94% and a net margin of 8.61%. As a group, analysts forecast that Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München will post 0.46 earnings per share for the current fiscal year.
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Company Profile
(
Get Free ReportMünchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.
Featured Stories

Before you consider Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München wasn't on the list.
While Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.